Nichols Weston - Insider Non-Derivative Transactions at TScan Therapeutics, Inc. (TCRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 31, 2023, Nichols Weston's relationship to TScan Therapeutics, Inc. (TCRX) is TenPercentOwner, and currently has 5,225,000 shares of Common Stock, and 5,240,000 shares of Common stock, $0.0001 par value per share Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TCRX insiders.
Data Source: SEC.
Nichols Weston - Insider Non-Derivative Transactions at TCRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 1, 2023 | Sell -- (Common Stock) | 400 | 2.51 | 5224600 |
| Jun 1, 2023 | Sell -- (Common Stock) | 15000 | 2.52 | 5225000 |
| Jun 1, 2023 | Sell -- (Common stock, $0.0001 par value per share Common Stock) | 10000 | 2.51 | 5240000 |